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18:30S-5S.The reliability of lung function tests in a quadriplegic patientPierre Emmanuel Noly, MD, Alex Arame, MD, Marc Riquet, PhD, MD, and
Franc¸oise Le Pimpec-Barthes, PhD, MD, Paris, FranceThere are few quadriplegic patients who require thoracic
surgery.1 Aweak capability to cough may lead to retention
of pulmonary secretions and consequently life-threatening
infectious complications,2 particularly during the postoper-
ative course. Surgery remains the only radical treatment of
endangering conditions, such as lung aspergilloma compli-
cated by hemoptysis.3 Lung resection usually requires a pre-
dicted postoperative forced expiratory volume in 1 second
(FEV1) exceeding 30%; otherwise, resection may be asso-
ciated with a high postoperative mortality.CLINICAL SUMMARY
A 35-year-old man was involved in a motor accident
(12 years previously) causing T8 paraplegia complicated
by phlebitis and pulmonary embolism. He underwent
T3-L3 arthrodesis 7 years later to correct post-traumatic
kyphoscoliosis that was complicated by C6 quadriplegia
(with partial left arm mobility) and several bacterial pneu-
monias resulting in destruction of the right upper lobe, fol-
lowed by aspergilloma formation and mild hemoptysis
occurring several times per day. Treatment with an oralantifungic drug was stopped because of liver complication
(cytolysis). Itraconazole proved to be ineffective. Asper-
gillous serology remained positive, and hemoptysis con-
tinued. Lobectomy was declined by 2 thoracic surgery
centers because of the patient’s low FEV1: 570 mL
(13% of the predicted value).
The patient was referred to the Georges Pompidou Euro-
pean Hospital. He had no dyspnea, and room air saturation
was 99% at rest. He was able to move himself using
a wheelchair, but he had swallowing problems and an in-
ability to cough. No abdominal muscle activity or accessory
respiratory muscle contraction was observed. After 2 weeks
in a pulmonary prehabilitation program, spirometry did not
improve. FEV1 was still 13%, vital capacity was 25%
(1350 mL), and diffusing capacity of the lung for carbon
monoxide was 37%. Arterial oxygen tension was 100 mm
Hg, and arterial carbon dioxide tension was 45 mm Hg.
However, except for an aspergilloma, the lung parenchyma
was disease-free on the computed tomography scan, and
lung perfusion was uniformly homogeneous in both lungs
on ventilation-perfusion scan. We suspected that the real re-
spiratory function was underestimated by spirometry and
not interpretable in this patient. C6 quadriplegia explained
the respiratory weakness with an FEV1 less than 20% of
predicted. A right upper lobectomy was performed by
video-assisted thoracoscopic surgery. A temporary prophy-
lactic tracheostomy was performed to manage postopera-
tive expectorating incapability problems and swallowing
difficulties. The postoperative course was uneventful. The
patient was weaned from mechanical ventilation within
24 hours, and the tracheostomy tube was removed on post-
operative day 9. Intense chest physiotherapy continuedgery c November 2012
Case Reportspostoperatively. The patient was symptom-free at the 5-year
follow-up with unchanged FEV1.
DISCUSSION
This case illustrates that the interpretation of respiratory
functional evaluation must not be considered indepen-
dently of the patient context. At first, surgery was declined
by overlooking the role of a neurologic deficit as the cause
of the inability to perform expiratory maneuvers. We
could not find other examples of lobectomy performed
in quadriplegic patients with such a low preoperative
FEV1. No functional data were available in the 3 lobecto-
mies (performed by standard thoracotomy) reported by
Rocco and colleagues,1 but the authors reported that pre-
operative evaluation may be limited, and the major em-
phasis must be on clinical expertise and arterial blood
gas analysis to approximately determine the surgical
risk. In the absence of diffuse pulmonary disease that ex-
plains major respiratory insufficiency, low preoperative
FEV1 may not necessarily constitute a contraindication
to surgery. In addition, vital capacity, which has been pro-
posed as a single global measure of overall ventilatory
function status in these cases,4 was not helpful. To avoid
postoperative pulmonary infectious complications related
to low expiratory flow rates and incapacity to expectorate,
temporary tracheostomy might be a good adjunct to the
surgical treatment. In a randomized controlled trial5 in-
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The Journal of Thoracic and Cara significantly lower rate of sputum retention was ob-
served in the group with prophylactic tracheostomy com-
pared with the control group, without early mortality
linked to infectious lung complication.CONCLUSIONS
The validity of pulmonary function tests in severe neuro-
logic impairment should be considered with caution. These
test results must not singly influence the decision-making
for the anticipated operation when other criteria seem nor-
mal (rest of parenchyma, oxygen saturation). Prevention
of complementary procedures, such as tracheostomy, might
help to obtain better postoperative results.References
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osteomyelitis and omentum flapChristian Dirk Taeger, MD, Ulrich Kneser, MD, and Raymund E. Horch, MD, Erlangen, GermanySternal wound infections represent potentially life-
threatening complications in patients undergoing cardio-
vascular surgery. Although the incidence ranges from
only 0.3% to 5%, the condition is associated withsignificant mortality of 14% to 47% in the published
data.1
Different approaches have been tried to manage post-
sternotomy osteomyelitis, including surgical revision fol-
lowed by open dressings or closed irrigation and
reconstruction with vascularized soft tissue flaps. The
omentum flap represents an alternative technique that
was primarily used in the past.2 Its use was hampered by
the additional surgical trauma, turning a ‘‘1-cavity’’ into
a ‘‘2-cavity’’ surgery, with a much wider range of possible
complications, such as pain, reduced thoracic compliance,
and a significant risk of hiatal and midline hernia
formation.1
The standard techniques of sternal wound coverage
such as the pectoralis major flap have limited applicability
in defects in the lower third of the sternum, and a craniallydiovascular Surgery c Volume 144, Number 5 e117
